James Gordon

Stock Analyst

(n/a)

# 7

Out of 4,648 analysts

6

Total ratings

n/a

Success rate

n/a

Average return

Main Sectors:

Top Industries:

Stocks Rated by James Gordon

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ARGX argenx SE	Maintains: Overweight	$500 → $640	$595.58	+7.46%	4	Aug 23, 2024
	GMAB Genmab	Downgrades: Neutral	n/a	$22.56	-	1	Aug 20, 2024
	FGEN FibroGen	Upgrades: Neutral	n/a	$0.32	-	1	Apr 7, 2021

argenx SE

Aug 23, 2024

Maintains: Overweight

Price Target: $500 → $640

Current: $595.58

Upside: +7.46%

Genmab

Aug 20, 2024

Downgrades: Neutral

Price Target: n/a

Current: $22.56

Upside: -

FibroGen

Apr 7, 2021

Upgrades: Neutral

Price Target: n/a

Current: $0.32

Upside: -